Assignee
THERACLONE SCIENCES INC
US·13 granted patents·12 pending applications·39 citations·filing 2009–2024
Top patents by PatentIndex Score
25 records- 0196US10087239B2Broadly neutralizing human immunodeficiency virus type 1 (HIV-1) GP120-specific monoclonal antibodyTHERACLONE SCIENCES INC·Filed 2016·Granted Oct 2, 2018·14 cites·7 claims
- 0295US9464131B2Broadly neutralizing human immunodeficiency virus type 1 (HIV-1) GP120-specific monoclonal antibodyTHERACLONE SCIENCES INC·Filed 2013·Granted Oct 11, 2016·18 cites·4 claims
- 0391US12312396B2Monoclonal antibodies directed against trimeric forms of the HIV-1 envelope glycoprotein with broad and potent neutralizing activityTHERACLONE SCIENCES INC·Filed 2024·Granted May 27, 2025·0 cites·32 claims
- 0491US11319362B2Methods of treating HIV-1 infection utilizing broadly neutralizing human immunodeficiency virus type 1 (HIV-1) GP120-specific monoclonal antibodiesTHERACLONE SCIENCES INC·Filed 2019·Granted May 3, 2022·3 cites·44 claims
- 0586US12018067B2Monoclonal antibodies directed against trimeric forms of the HIV-1 envelope glycoprotein with broad and potent neutralizing activityTHERACLONE SCIENCES INC·Filed 2023·Granted Jun 25, 2024·0 cites·29 claims
- 0685US10865234B2Monoclonal antibodies directed against trimeric forms of the HIV-1 envelope glycoprotein with broad and potent neutralizing activityTHERACLONE SCIENCES INC·Filed 2019·Granted Dec 15, 2020·1 cites·7 claims
- 0783US10836811B2Broadly neutralizing human immunodeficiency virus type 1 (HIV-1) GP120-specific monoclonal antibodyTHERACLONE SCIENCES INC·Filed 2017·Granted Nov 17, 2020·1 cites·4 claims
- 0881US10407493B2Monoclonal antibodies directed against trimeric forms of the HIV-1 envelope glycoprotein with broad and potent neutralizing activityTHERACLONE SCIENCES INC·Filed 2019·Granted Sep 10, 2019·1 cites·20 claims
- 0979US11845789B2Methods of treating HIV-1 infection utilizing broadly neutralizing human immunodeficiency virus type 1 (HIV-1) GP120-specific monoclonal antibodiesTHERACLONE SCIENCES INC·Filed 2021·Granted Dec 19, 2023·0 cites·15 claims
- 1077US7982012B2Compositions and methods for the therapy and diagnosis of cytomegalovirusTHERACLONE SCIENCES INC·Filed 2009·Granted Jul 19, 2011·1 cites·11 claims
- 1176US11584789B2Monoclonal antibodies directed against trimeric forms of the HIV-1 envelope glycoprotein with broad and potent neutralizing activityTHERACLONE SCIENCES INC·Filed 2020·Granted Feb 21, 2023·0 cites·31 claims
- 1269US10239934B2Monoclonal antibodies directed against trimeric forms of the HIV-1 envelope glycoprotein with broad and potent neutralizing activityTHERACLONE SCIENCES INC·Filed 2018·Granted Mar 26, 2019·0 cites·14 claims
- 1365US2015191531A1Compositions and methods for the therapy and diagnosis of cytomegalovirus infectionsTHERACLONE SCIENCES INC·Filed 2014·Application pending·0 cites
- 1462US2014135480A1Compositions and Methods for the Therapy and Diagnosis of InfluenzaTHERACLONE SCIENCES INC·Filed 2013·Application pending·0 cites
- 1560US9920111B2Monoclonal antibodies directed against trimeric forms of the HIV-1 envelope glycoprotein with broad and potent neutralizing activityTHERACLONE SCIENCES INC·Filed 2015·Granted Mar 20, 2018·0 cites·8 claims
- 1657US2015104459A1Compositions and Methods for the Therapy and Diagnosis of InfluenzaTHERACLONE SCIENCES INC·Filed 2014·Application pending·0 cites
- 1757US2015086555A1Anti-Hemagglutinin Antibody Compositions and Methods of Use ThereofTHERACLONE SCIENCES INC·Filed 2014·Application pending·0 cites
- 1856US2015098948A1Compositions And Methods For The Therapy And Diagnosis Of InfluenzaTHERACLONE SCIENCES INC·Filed 2014·Application pending·0 cites
- 1954US2014341923A1Human Rhinovirus (HRV) AntibodiesTHERACLONE SCIENCES INC·Filed 2014·Application pending·0 cites
- 2054US2015125423A1Human m2e peptide immunogensTHERACLONE SCIENCES INC·Filed 2015·Application pending·0 cites
- 2152US2013158238A1Compositions and Methods for the Therapy and Diagnosis of InfluenzaTHERACLONE SCIENCES INC·Filed 2013·Application pending·0 cites
- 2252US2014363441A1Compositions and methods for the therapy and diagnosis of influenzaTHERACLONE SCIENCES INC·Filed 2014·Application pending·0 cites
- 2351US2011033476A1Compositions and methods for the therapy and diagnosis of influenzaTHERACLONE SCIENCES INC·Filed 2010·Application pending·0 cites
- 2448US2015152166A1Compositions and methods for the therapy and diagnosis of cytomegalovirusTHERACLONE SCIENCES INC·Filed 2014·Application pending·0 cites
- 2544US2014328797A1Human rhinovirus (hrv) antibodiesTHERACLONE SCIENCES INC·Filed 2014·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when THERACLONE SCIENCES INC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →